Warner Bros.'s $437M Box-Office Year Lands Inside Paramount Skydance's $44.4B Bond Deal — The Math the Skydance Pitch Never Modeled

Paramount Skydance is buying a major-studio machine that has not opened a Western revenue for twelve straight months — and the opening weekend of Warner Bros. Discovery's last film before close deepened the hole. Tom Cruise's satire 'Digger,' shot in VistaVision on a $125M greenlit budget that sources say ballooned to $160–180M, opened to $8M domestically and added $12M internationally for a $20M worldwide tally — Tom Cruise's lowest debut since 2007's 'Lions for Lambs' opened to $6.7M, per Deadline. The New York Times pegs the film's likely loss at $125–150M.

The $44.4B bond offering Paramount Skydance launched on Sept. 28 priced in two days, but the new paper sold off sharply on its first trading session. Eight-year dollar notes changed hands around96 cents on the dollar, leaving investors nursing more than $100M of paper losses on the investment-grade tranche alone, per Bloomberg. The $6B, 8.25% second-lien junk tranche due 2031 cleared at 97.5 — more than two points below par — and the cost of betting against Paramount's credit hit a 17-year high, the Bloomberg/Quartz coverage notes. The class B shares fell 9.6% on the bond-pricing day, their steepest drop since December.

Three investors in the high-grade order book evaporated when banks tightened spreads, per Bloomberg. The $7M-per-day ticking fee that started accruing Oct. 1 gives Paramount Skydance a hard reason to close before the Oct. 6 anticipated date — but it cannot force the studios to start printing tickets. That job falls on the same slate that just delivered Digger, a $170M-budget 'Supergirl' that earned $38.6M domestically and $62.6M worldwide, and 'The Bride!' — $80–90M budget, $23–24M global.

The Sept. 21 antitrust settlement that cleared the way for the deal locked the combined company into a release cadence Warner Bros. has not come close to meeting. Paramount Skydance must release at least 30 films per year in U.S. theaters for five years, spend an extra $1.5B on U.S. production over five years, and pay $30M for every film it falls short, with half going to the healthcare fund, per the CBS News summary. The penalty escalates to a forced sale of its minority stake in Miramax if the combined studio misses the quota — a divestiture term embedded inside a film-distribution consent decree.

For context, Warner Bros. has released seven films in 2026 according to multiple trade outlets — together grossing roughly $674M worldwide — and Paramount's own Q2 2026 earnings showed Studios revenue up 16% with DTC up 9%, the only segment in the acquirer growing on its own. The settlement also prohibits either party from selling the Paramount Studios or Warner Bros. lots in California for five years, which strips out one potential cash-extraction lever while the bond book amortizes.

The 30-film commitment is a direct revenue uplift for theatrical exhibitors. The major chains were offered legally enforceable contracts in writing as part of the antitrust remedy, per Variety's earlier coverage — locking in volume that a studio with a collapsing slate was not going to deliver on its own. Theatrical operators carry a structurally higher take rate when ticket volume normalizes, and the largest U.S. circuit plus the No. 3 are the most direct beneficiaries. Premium-format operators sit in the same supply chain because any of the 30 mandated releases can be slotted into IMAX/PLF auditoriums for higher per-screen economics.